🔗 Share this article

A shadow market for unapproved slimming drugs is propelled by social media fitness personalities and vendors on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning effects. Viewers are encouraged to message these accounts directly for supplier links, while also obtaining discount codes.

Active Commerce on Social Networks

Additionally, a robust market exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and claims of next-day UK delivery. Vendors promote the drug there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Voice Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals administering substances of unknown origin.

Several experts said the popularity for retatrutide could be connected to the increasing cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Enforcement

Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.

Some content creators try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate pharmaceutical, marketing, and customer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Content Removal

According to TikTok, the service has taken down problematic material and prohibited related hashtags and search suggestions. The organization stated it was committed to maintaining the service safe and investing in strengthening compliance measures.

Digital Marketplace Activities

Research also discovered groups with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, populated with images of slimming results, glowing reviews and detailed guides for preparing or injecting at home.

After minutes of entering one group, a vendor shared WhatsApp details, where most purchases take place. The vendor provided an guidebook and promised delivery within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. Not one asked about body mass, health issues or previous experience.

Item Information and Costs

Inside these groups, posts display dark colored parcels with Royal Mail stickers, claiming to include new batches. One message read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory answers varying between a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service stated it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is valid, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are using social media. But counterfeit treatments are highly risky. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.

Her team has already seen individuals injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to potentially significant medical dangers”.